Area of research
Ophthalmology · Molecular Biology
Research interest
Research interests include Retinal Diseases and Treatments, Retinal Development and Disorders, Retinal and Macular Surgery, and Retinal and Optic Conditions.
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema
Suprachoroidal Delivery of Viral and Nonviral Vectors for Treatment of Retinal and Choroidal Vascular Diseases.
Sustained Suppression of VEGF for Treatment of Retinal and Choroidal Vascular Diseases.
Stair-Case/Honeycomb Maculopathy in Alport Syndrome: A Case Report.
Suppression of choroidal neovascularization by nonviral gene transfer of pigment epithelium-derived factor
Suprachoroidal gene transfer with nonviral nanoparticles in large animal eyes.
Heterogeneity in disease activity, frequency of treatments, and visual outcomes among patients with retinal vein occlusion: relationship between injection need and vision with as-needed ranibizumab.
Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly Injections
Peripheral photocoagulation not the answer for DMO.
Oxidative stress-induced alterations in retinal glucose metabolism in Retinitis Pigmentosa.
Viewpoints: Dual-blocking antibody against VEGF-A and angiopoietin-2 for treating vascular diseases of the eye
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases.
Proteosomal degradation impairs transcytosis of AAV vectors from suprachoroidal space to retina.
Comment on "Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases".
Retinal vascular occlusions
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress
Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases
Gelling hypotonic polymer solution for extended topical drug delivery to the eye
Gelling hypotonic polymer solution for extended topical drug delivery to the eye.
Oral N-acetylcysteine improves cone function in retinitis pigmentosa patients in phase I trial.
A transcriptome-wide association study based on 27 tissues identifies 106 genes potentially relevant for disease pathology in age-related macular degeneration
Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles.
Suprachoroidal gene transfer with nonviral nanoparticles.
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression
AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression
A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular Neovascularization
Metipranolol promotes structure and function of retinal photoreceptors in the rd10 mouse model of human retinitis pigmentosa.